- List
- By Topic
- On Map
- Search Details

17544497 [PUBMED-IDS]
Need help? See RSS Feeds
Choose a feed type:

17544497 [PUBMED-IDS] (4 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT00003159 | Completed | Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer |
|
|
Interventional | Phase 3 |
|
Other |
|
|
600 | All | Child, Adult, Senior | NCT00003159 | CDR0000065952 MRC-LU22 EORTC-08012 EU-97016 ISRCTN25582437 |
August 1997 | June 2007 | January 27, 2003 | December 4, 2013 |
|
|||
2 | NCT00924209 | Terminated Has Results |
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
7 | All | 18 Years to 70 Years (Adult, Senior) | NCT00924209 | 090107 09-C-0107 |
March 2009 | September 2011 | September 2011 | June 18, 2009 | August 30, 2012 | August 21, 2012 |
|
|
3 | NCT01833572 | Unknown † | Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC |
|
|
Interventional | Phase 2 |
|
Other |
|
|
42 | All | 18 Years and older (Adult, Senior) | NCT01833572 | ISSIRES0081 FUSCC1301 |
May 2013 | December 2014 | April 17, 2013 | May 29, 2013 |
|
|||
4 | NCT02259621 | Recruiting | Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02259621 | J1414 NA_00092076 |
NA_00092076 | September 2014 | January 2023 | January 2023 | October 8, 2014 | November 6, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.